![](/img/cover-not-exists.png)
Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1
Parkes, David G, Mace, Kenneth F, Trautmann, Michael EVolume:
8
Language:
english
Journal:
Expert Opinion on Drug Discovery
DOI:
10.1517/17460441.2013.741580
Date:
February, 2013
File:
PDF, 741 KB
english, 2013